Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

BUY
$86.5 - $128.27 $1.14 Million - $1.69 Million
13,168 New
13,168 $1.25 Million
Q1 2022

May 16, 2022

SELL
$101.96 - $128.34 $851,671 - $1.07 Million
-8,353 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$106.37 - $130.68 $888,508 - $1.09 Million
8,353 New
8,353 $1.08 Million
Q2 2021

Aug 13, 2021

SELL
$83.84 - $104.76 $355,984 - $444,810
-4,246 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$78.68 - $90.67 $334,075 - $384,984
4,246 New
4,246 $355,000
Q2 2020

Aug 14, 2020

SELL
$57.54 - $76.95 $121,006 - $161,825
-2,103 Closed
0 $0
Q1 2018

May 15, 2018

SELL
$37.19 - $47.45 $11,231 - $14,329
-302 Reduced 12.56%
2,103 $293,000
Q4 2017

Feb 13, 2018

SELL
$33.79 - $39.39 $16,557 - $19,301
-490 Reduced 16.93%
2,405 $271,000
Q3 2017

Nov 14, 2017

BUY
$36.29 - $38.83 $105,059 - $112,412
2,895
2,895 $316,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Lombard Odier Asset Management (Europe) LTD Portfolio

Follow Lombard Odier Asset Management (Europe) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lombard Odier Asset Management (Europe) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Lombard Odier Asset Management (Europe) LTD with notifications on news.